Evidence map›Paper›PMID 21303368›Full record

ArticleTransfusion2011

Distribution of parvovirus B19 DNA in blood compartments and persistence of virus in blood donors.

Tzong-Hae Lee, Steven H Kleinman, Li Wen, Lani Montalvo, Deborah S Todd, David J Wright, Leslie H Tobler, Michael P Busch, NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II)

Open access · greenAbstract read
In one paragraph

Article in Transfusion, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Prevalence and Viral Load of Human Parvovirus B19 (B19V) Among Blood Donors in South-East Brazil.Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion · 2016
    Article
  8. Characterization of Markers of the Progression of Human Parvovirus B19 Infection in Virus DNA-Positive Plasma Samples.Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2015
    Article
  9. Article
  10. Molecular virology in transfusion medicine laboratory.Blood transfusion = Trasfusione del sangue · 2013
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Tzong-Hae LeeBlood Systems Research Institute, San Francisco, California, USA.
Steven H Kleinman
Li Wen
Lani Montalvo
Deborah S Todd
David J Wright
Leslie H Tobler
Michael P Busch
NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II)
University of California, San Francisco · USWestat (United States) · USBlood Systems Research Institute · USUniversity of British Columbia · CA

Funding

REDS-II Central Laboratory-268047175-268047175N01HB047175 · HB · WESTAT. INC. · PI BUSCH, MICHAEL PAUL · 2005 to 2006
–
CYTOSOLIC CA2+IONOPHORES FOR FLUORESCENCE AND L9F NMRR44HL047175 · NHLBI · COVALENT ASSOCIATES, INC. · PI LANGMUIR, MARGARET E · 1991 to 1992
–
NHLBI NIH HHS HHSN268200417175CNHLBI NIH HHS HHSN268200517181CNHLBI NIH HHS N01 HB047175NHLBI NIH HHS N01-HB-47175NHLBI NIH HHS N01-HB-57181ODCDC CDC HHS HHSN268200417175C
6 · The paper itself

Abstract

backgroundBecause the receptor for parvovirus B19 (B19V) is on red blood cells (RBCs), we investigated B19V distribution in blood by in vitro spiking experiments and evaluated viral compartmentalization and persistence in natural infection. STUDY DESIGN AND

methodsTwo whole blood (WB) protocols (ultracentrifugation and a rapid RBC lysis and removal protocol) were evaluated using quantitative real-time polymerase chain reaction. WB was spiked with known concentrations of B19V and recovery in various blood fractions was determined. The rapid RBC lysis and removal protocol was then used to compare B19V concentrations in 104 paired WB and plasma samples collected longitudinally from 43 B19V-infected donors with frozen specimens in the REDS Allogeneic Donor and Recipient Repository (RADAR).

resultsIn B19V spiking experiments, approximately one-third of viral DNA was recovered in plasma and two-thirds was loosely bound to RBCs. In the immunoglobulin (Ig)M-positive stage of infection in blood donors when plasma B19V DNA concentrations were greater than 100 IU/mL, median DNA concentrations were approximately 30-fold higher in WB than in plasma. In contrast, when IgM was absent and when the B19V DNA concentration was lower, the median WB-to-plasma ratio was approximately 1. Analysis of longitudinal samples demonstrated persistent detection of B19V in WB but declining ratios of WB to plasma B19V with declining plasma viral load levels and loss of IgM reactivity.

conclusionsThe WB-to-plasma B19V DNA ratio varies by stage of infection, with 30-fold higher concentrations of B19V DNA in WB relative to plasma during the IgM-positive stage of infection followed by comparable levels during persistent infection when only IgG is present. Further study is required to determine if this is related to the presence of circulating DNA-positive RBCs derived from B19V-infected erythroblasts, B19V-specific IgM-mediated binding of virus to cells, or other factors.

Indexed as

Blood DonorsDNA, ViralHumansLeukocytesParvoviridae InfectionsParvovirus B19, HumanPlasmaPolymerase Chain ReactionDNA, Viral

Identifiers

PMID21303368
PMCPMC3591477
OpenAlexW1567206321

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.